PARIS, FR, MONTREAL, CA — Ipsen (Euronext: IPN; ADR: IPSEY), Université de Montréal and IRICoR announce that Ipsen has exercised its option to acquire exclusive rights to a pre-clinical stage program… Read More
VANCOUVER, BC — Gene Bio Medical is proud to announce the release of its groundbreaking Molecular Imprint Diagnostic Solutions. This innovative technology is set to revolutionize the healthcare industry, providing… Read More
CHARLOTTETOWN, PE – Today, the Government of Canada and the Government of British Columbia announced a combined $7.2-million investment to create a new biomanufacturing training centre at BCIT, where in partnership… Read More
Intense interest in PharmAla’s best-in-class manufacturing and regulatory excellence continues as PharmAla examines further Australian opportunities VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that,… Read More
Completed NVG-291 dosing of subjects in Phase 1 clinical trial Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury planned to start in Q3 2023 NVG-291 has… Read More
